Rapid Sepsis Test Reduces Mortality by 42% in Academic Medical Center Study
The eight-minute test also shortened hospital stays by nearly two days at Froedtert Hospital, reinforcing previous multi-site evidence.
Category: Sepsis
Sepsis
Latest
Sepsis
Latest
Bacterial Infections Could be ‘Sniffed Out’ With New Tech
Researchers propose developing tiny chemical sensors that detect VOCs in bodily fluids to rapidly diagnose bacterial infections.
Sepsis
Latest
Trinity Biotech Invests in Novus Diagnostics to Accelerate Rapid Sepsis Testing
Trinity Biotech made a strategic investment in Novus Diagnostics to accelerate the development of a 15-minute bedside test for sepsis.
Cytovale Expands FDA-Cleared Sepsis Detection Test to Wisconsin Health Network
The Froedtert & Medical College of Wisconsin will screen patients in their network with the IntelliSep test for early sepsis detection.
Read More
Machine Learning Could Revolutionize Diagnosis of Multiple Myeloma and Sepsis
Advances in AI and data science highlight innovative machine learning models that predict patient outcomes in multiple myeloma and sepsis.
Read More
Cytovale’s Sepsis Diagnostic Triages First 5,000 Patients
Cytovale’s IntelliSep test helped support the sepsis management program for Our Lady of the Lake Regional Medical Center.
Read More
AI Enables Effective Antibiotic Treatment of Sepsis
AI-based antimicrobial susceptibility test method promises rapid prediction of antimicrobial resistance using blood of sepsis patients.
Read More
Nasal Microbiota is a Potential Sepsis Diagnostic Biomarker
A new study reveals that the nasal microbiota of ICU patients is more effective than gut microbiota in distinguishing sepsis from non-sepsis.
Read More
Bruker Expands Clinical Microbiology and Infection Diagnostics Portfolio
Bruker enhanced diagnostic solutions in microbial identification, antimicrobial susceptibility testing, early sepsis diagnostics, and more.
Read More
Software for Rapid Sepsis Diagnosis Gets FDA De Novo Marketing Authorization
The Sepsis ImmunoScore is an AI/machine learning software as a medical device to guide rapid diagnosis and prediction of sepsis.Â
Read More
Cytovale’s Sepsis Test Shows Improved Patient Care and Cost Savings
Find out how Cytovale’s IntelliSep test reduced cost of care and improved the efficiency of sepsis care for a large U.S. academic center.
Read More
New Analysis Method Melts DNA to Detect Pathogens Faster
This method is faster than blood cultures and is less likely to generate false positives compared to other DNA detection-based technologies.
Read More
New Sepsis Test Provides Faster and Reliable Results
Doctors from Norway received test results two days earlier than before when they tested a new way to analyze blood for suspected sepsis.Â
Read More
Advances in Pediatric Sepsis Biomarkers
A recent review of advances in pediatric sepsis biomarkers provides an overview of research advancements across various omics levels.
Read More
New Research Supports Diagnosis of Sepsis in Children
Researchers harnessed artificial intelligence to analyze data from over 3.5 million children suffering from sepsis.
Read More
Bluejay Diagnostics Evaluates Test for Sepsis Patient Care
The Symphony System is designed to address the need for simple, reliable, rapid, near-patient sepsis testing.
Read More
New Study Highlights Need for Improved Sepsis Diagnosis and Triage
Cytovale detailed the publication of a new peer-reviewed study that highlights the need for rapid sepsis testing.
Read More
Inflammatix Acute Infection and Sepsis Test System Gets FDA Breakthrough Device Designation
Inflammatix says that the U.S. FDA has granted Breakthrough Device Designation for its TriVerity Acute Infection and Sepsis Test System.Â
Read More